Dose-Limiting Toxicities (DLTs) are side effects of a drug that prevent an increase in dosage. Identifying DLTs is crucial during the dose-escalation phase of clinical trials. Common DLTs include severe neutropenia, thrombocytopenia, and organ dysfunction. Understanding DLTs helps in determining the MTD and ensuring patient safety.
